Sokal Score (CML Prognosis)
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۰۰ • واحد: years
حداقل ۰ — حداکثر ۴۰ • واحد: cm
حداقل ۲۰ — حداکثر ۳۰۰۰ • واحد: x10^9/L
حداقل ۰ — حداکثر ۳۰ • واحد: %
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–0.8
- Intermediate risk0.8–1.2
- High risk1.2–100
The Sokal Score (CML Prognosis) calculates determining thromboembolic risk, heparin-induced thrombocytopenia probability, and bleeding diathesis. Key inputs include age. Scores guide initiating targeted anticoagulation therapy, platelet monitoring, or hematology specialist referral. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
CML prognostic score at diagnosis: <0.8 low, 0.8-1.2 intermediate, >1.2 high risk.
Clinical Indication
The Sokal Score (CML Prognosis) is indicated for bedside clinical practice to support CML prognostic score at diagnosis: <0.8 low, 0.8-1.2 intermediate, >1.2 high risk.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with coagulopathy, thrombocytopenia, venous thromboembolism (DVT/PE), or hematologic neoplasms. Clinical application is indicated across Hematology-oncology services, bone marrow transplant units, anticoagulation clinics, and acute medical wards.
Limitations & Contraindications
Severe thrombocytopenia with concomitant microvascular thrombosis (TTP, HIT, DIC) represents a medical emergency requiring rapid intervention.
Clinical Pearls & Action Plan
Detailed history of heparin exposure, platelet count kinetics, and comprehensive coagulation profiles are vital in consumptive coagulopathies.
exp(0.0116x(age-43.4) + 0.0345x(spleen-7.51) + 0.188x((plt/700)^2-0.563) + 0.0887x(blasts-2.1))
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Age(years) |
| spleen_cm | float | Yes | Spleen palpable below costal margin(cm) |
| platelets | float | Yes | Platelets(x10^9/L) |
| blasts | float | Yes | Peripheral blasts(%) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0.8 | Low risk | Low risk |
| 0.8–1.2 | Intermediate risk | Intermediate risk |
| 1.2–100 | High risk | High risk |
Evidence-Based References (EBM)
- Sokal JE, Cox EB, Baccarani M, et al. Prognostic discrimination in good-risk chronic granulocytic leukemia. Blood. 1984;63(4):789-799.